Pharming extends Ruconest distribution agreement with Cytobioteck
9 February 2016 | By Victoria White
Under the extended agreement, Cytobioteck will also exclusively distribute Ruconest in Argentina, Costa Rica, the Dominican Republic and Panama...
List view / Grid view
News
Gilotrif to gain ground in the NSCLC treatment markets outside the US
9 February 2016 | By Victoria White
An analyst from GlobalData says promising clinical trial data for Gilotrif (afatinib) will strengthen the drug’s position in NSCLC treatment markets outside the US...
SMC accepts five new medicines; rejects eculizumab
9 February 2016 | By Victoria White
The committee was unable to accept eculizumab as it was "not considered to represent an effective use of NHS Scotland’s resources"...
James Robinson named as President, Americas Operations for Astellas
9 February 2016 | By Victoria White
Effective from 1st April 2016, Robinson will have responsibility for the company's operations in North and South America...
Executive leadership team named for the combined Allergan Pfizer business
8 February 2016 | By Victoria White
The close of the transaction to combine Pfizer and Allergan is expected in the second half of 2016, and is subject to certain conditions...
BIO-Europe Spring® 2016 Event in Sweden this April will bring 2,000+ life science executives to Stockholm-Uppsala region
8 February 2016 | By EBD Group
The tenth annual BIO-Europe Spring® springtime international life science partnering conference will be held in Stockholm, Sweden, April 4–6, 2016...
RedHill Biopharma and IZI enter RP101 collaboration
8 February 2016 | By Victoria White
The research collaboration will test RP101 in preclinical oncology models in combination with standard-of-care chemotherapies to support existing Phase I and Phase II clinical data...
New toolkit informs of the risks of taking valproate during pregnancy
8 February 2016 | By Victoria White
Valproate is associated with a risk of birth defects and developmental disorders in children born to women who take the treatment during pregnancy...
NICE says ‘no’ to alirocumab in draft guidance
8 February 2016 | By Victoria White
NICE was concerned that alirocumab had not been compared with the combination therapy of ezetimibe plus a statin and that trials of the drug were not able to provide robust information on cardiovascular outcomes...
FDA approves expanded use of Daklinza in HCV genotypes 1 and 3
8 February 2016 | By Victoria White
The expanded label for Daklinza includes three additional patient populations: HCV patients with HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV...
ImmunoGen and Merck collaborate for ovarian cancer trial
5 February 2016 | By Victoria White
The companies are to are to assess ImmunoGen’s mirvetuximab soravtansine in combination with Merck’s Keytruda (pembrolizumab) in FRα-positive ovarian cancer...
Public Accounts Committee publishes report on the Cancer Drugs Fund
5 February 2016 | By Victoria White
A Public Accounts Committee has released its recommendations for the reform of the Cancer Drugs Fund...
Honeywell completes acquisition of research chemicals business from Sigma-Aldrich
5 February 2016 | By Honeywell
The acquisition broadens Honeywell’s research chemicals portfolio and expands the company's global reach...
Aridhia’s Dr David Sibbald honoured with Outstanding Contribution Award
5 February 2016 | By Victoria White
Dr David Sibbald OBE, co-founder and Chairman of Aridhia, was awarded the ‘Outstanding Contribution Award’ at the Scottish Enterprise Life Sciences Awards...
Muzammil Mansuri is Sanofi’s new Executive Committee member
5 February 2016 | By Victoria White
Mr. Mansuri joins Sanofi from Gilead Sciences and will take the position of Executive Vice President, Strategy & Business Development...
